Opioid poisoning deaths in New Zealand (2001-2002)

New Zealand Medical Journal

Volumn 118, Issue 1209, 2005, Pages

  Reith, David M ^a   Fountain, John S ^b   Tilyard, Murray ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; DEXTROPROPOXYPHENE NAPSILATE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIAMORPHINE; DIHYDROCODEINE; METHADONE; MORPHINE; MORPHINE SULFATE; OPIATE DERIVATIVE; NARCOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICAL INJURY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG INTOXICATION; DRUG MONITORING; DRUG UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; NEW ZEALAND; PRESCRIPTION; DRUG CONTROL; FEMALE; INTOXICATION; MALE; MIDDLE AGED; MORTALITY; STANDARD; STATISTICS; SUICIDE;

ADOLESCENT; ADULT; AGED; DRUG AND NARCOTIC CONTROL; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; NARCOTICS; NEW ZEALAND; POISONING; PRESCRIPTIONS, DRUG; PROPOXYPHENE; SUICIDE;

EID: 17844382452     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hickman M, Madden P, Henry J, et al. Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction. 2003;98:419-25.
2. Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97:39-47.
3. Hawton K, Simkin S, Deeks J. Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings. BMJ. 2003;326:1006-8.
4. Jonasson U, Jonasson B, Holmgren P, Saldeen T. The prevalence of dextropropoxyphene in autopsy blood samples. Forensic Sci Int. 1998;96:135-42.
5. Buckley NA, Whyte IM, Dawson AH, et al. Correlations between prescriptions and drugs taken in self-poisoning. Implications for prescribers and drug regulation. Med J Aust. 1995;162:194-7.
6. Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet. 1996;31:419-22.
7. Stata C. STATA for Windows. In. 8 ed. College Station, TX 77840: Stata Corporation; 2003.
8. Capella D. Descriptive tools and analysis. In: Dukes MNG, editor. Drug Utilization Studies: Methods and Uses: World Health Organization; 1993. p55-78.
9. Bateman DN, Afshari R. Co-proxamol and suicide: Licence needs to be changed. BMJ. 2003;327:287.
10. Jonasson B, Jonasson U, Saldeen T. The manner of death among fatalities where dextropropoxyphene caused or contributed to death. Forensic Sci Int. 1998;96:181-7.
11. Li Wan Po A, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ. 1997;315:1565-71.
12. Poulsen L, Brosen K, Arendt-Nielsen L, et al. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol. 1996;51:289-95.
13. Leander P, Hove LD, Ott P. Who dies of morphine and dextropropoxyphene intoxication? Danish experiences from the period 1979-1992. Ugeskr Laeger 1997;159:2370-474.
14. Fryers PT, Geraghty M, Hall C. Co-proxamol and suicide: Availability of co-proxamol has been successfully reduced in Doncaster. BMJ. 2003;327:287.
15. Jonasson B, Jonasson U, Saldeen T. Suicides may be overreported and accidents underreported among fatalities due to dextropropoxyphene. J Forensic Sci. 1999;44:334-8.
16. Sibley J, Dickson S. Methadone-related deaths in New Zealand. N Z Med J. 1999;112:303.
17. Krantz MJ, Lewkowiez L, Hays H, et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137:501-4.
18. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw-Hill; 2001, p569-619.
19. Milroy CM, Forrest ARW. Methadone deaths: a toxicological analysis. J Clin Pathol. 2000;53:277-81.
20. Oliver P, Keen J. Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997-2000. Addiction. 2003;98:191-7.
21. Tagliaro F, De Battisti Z, Smith FP, Marigo M. Death from heroin overdose: findings from hair analysis. Lancet 1998;351:1923-5.
22. Seymour A, Black M, Jay J, et al. The role of methadone in drug-related deaths in the west of Scotland. Addiction 2003;98:995-1002.
23. Hall W, Lynskey M, Degenhardt L. Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995. Drug Alcohol Depend. 2000;57:247-54.
24. Bedford KR, Nolan SL, Onrust R, Siegers JD. The illicit preparation of morphine and heroin from pharmaceutical products containing codeine: 'homebake' laboratories in New Zealand. Forensic Sci Int. 1987;34:197-204.
25. Wilkins C, Bhatta K, Casswell S. The emergence of amphetamine use in New Zealand: findings from the 1998 and 2001 National Drug Surveys. N Z Med J. 2002;115(1166). URL: http://www.nzma.org.nz/journal/115-1166/256.